冷冻保存主动脉同种移植物行气管支气管重建:TRITON-01登记研究50例结果
TRITON-01前瞻性登记纳入50例因广泛气管支气管病变接受冷冻保存主动脉同种移植物气管重建的患者,恶性41例、良性9例,术中13例使用静脉-静脉ECMO。30天死亡率为4%(n=2),主要并发症30%(n=15),末次随访74%(n=37)存活,支架相关肉芽肿最常见(n=26),15例(30%)因功能性新软骨形成成功移除支架。
要点
- 冷冻保存主动脉同种移植物气管重建30天死亡率为4%,主要并发症发生率30%。
- 末次随访74%患者存活,支架相关肉芽肿为最常见远期并发症(n=26)。
- 15例(30%)因功能性新软骨形成成功移除支架。
核心结论
- 冷冻保存主动脉同种移植物行气管替代似为有效且可持续的技术,死亡率和并发症率可接受。
- 后续研究旨在优化软骨再生并提高移植物生物利用度。
研究设计与样本
- 收集手术指征、手术细节、术后死亡与并发症、远期并发症、支架管理及末次随访(2025年1月2日)状态。
主要发现
- 50例患者(女性25例)平均年龄55.1岁(范围20-79岁),广泛气管支气管病变恶性41例、良性9例。
- 术中13例使用静脉-静脉ECMO,气管支气管重建类型1、2、3、4分别为20、15、4、11例,12例附加肺切除,3例R1切除。
- 30天术后死亡率4%(n=2),主要并发症15例(30%)。
- 末次随访(1个月至14年)74%(n=37)存活,支架相关肉芽肿最常见(n=26),15例(30%)成功移除支架。
临床怎么用
- 对于广泛气管支气管病变,冷冻保存主动脉同种移植物气管替代可作为可选术式,需关注支架相关肉芽肿并评估新软骨形成后支架移除可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tracheal replacement remains a major challenge in thoracic surgery. We report the outcomes of the TRITON-01 registry, which includes 50 patients who underwent tracheal replacement using a cryopreserved aortic allograft performed by our surgical team. METHODS: Prospective data were collected for each patient, including indication for surgery, operative details, postoperative mortality and morbidity, late complications, stent management, and patient status at last follow-up on January 2, 2025. RESULTS: Between October 2009 and January 2025, 50 patients (25 females) with a mean age of 55.1 years (range, 20-79 years) underwent tracheal replacement. Extensive tracheobronchial lesions were malignant in 41 cases and benign in 9 cases. Veno-venous extracorporeal membrane oxygenation (ECMO) was used intraoperatively in 13 patients. Tracheobronchial reconstructions were classified as type 1, 2, 3, and 4 in 20, 15, 4, and 11 patients, respectively. Additional lung resections (lobectomy, bilobectomy, or pneumonectomy) were performed in 12 cases. Incomplete (R1) resection was observed in 3 patients. Thirty-day postoperative mortality was 4% (n = 2). Major complications occurred in 15 patients (30%). At the last follow-up (ranging from 1 month to 14 years), 74% of patients (n = 37) were alive. Stent-related granuloma formation was the most common late complication (n = 26), and stent removal was successfully achieved in 15 (30%) patients due to the development of functional neocartilage. CONCLUSIONS: Tracheal replacement with cryopreserved aortic allografts appears to be an effective and sustainable technique, with acceptable mortality and morbidity rates. Ongoing investigations aim to optimize cartilage regeneration and enhance the bioavailability of grafts. CLINICAL REGISTRATION NUMBER: Clinicaltrials.gov Identifier: NCT04263129.
引用
- Martinod E, Onorati I, Radu DM, et al. Tracheobronchial Replacement Using Cryopreserved Aortic Allografts: Results in 50 Patients (TRITON-01 Registry). Eur J Cardiothorac Surg. 2026. PMID: 41390914. doi:10.1093/ejcts/ezaf445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。